In a breakthrough development that offers significant hope for millions suffering from Alzheimer's disease, a click here new drug has shown remarkable results in clinical trials. The drug, known as Neurogen, targets the underlying processes of the disease and has been shown to slowing or even halting the progression of cognitive decline. Early stud